A C20 fatty diacid moiety is attached to the lysine residue at position 17 through an AEEA-Glu linker, supporting albumin binding and an extended pharmacokinetic half-life in research models
Ye Y, Chen A, Li L, Liang Q, Wang S, Dong Q, et al
If your version of the tool includes an Other or custom vial amount field, enter 100 mg (or convert to the unit the input expects) and the outputs will scale accordingly
This short report lacked details, including the amount of B12 provided to the mothers
Key Features Verified 99% Purity HPLC/MS tested for consistent, reproducible results Pulse-Friendly Pharmacology Short-acting profile to model natural GH pulsatility Selective GHRH-R Agonism Designed to engage pituitary somatotroph receptors Timing Experiments Suited for circadian/sleep-aligned release investigations Stack-Compatible Integrates into multi-pathway endocrine and recovery research GMP-Compliant, USA-Made Manufactured for quality and batch-to-batch reliability COA Included Full lot documentation with every vial Mechanism of Action CJC-1295 (No DAC) activates the growth hormonereleasing hormone receptor on anterior pituitary cells, initiating cAMP/PKA signaling that promotes synthesis and pulsatile secretion of GH